Gsk (GSK) Gross Margin (2009 - 2026)
Gsk (GSK) posted quarterly Gross Margin of 73.05% for Q2 2026, up 16.0% year-over-year from 62.98% in Q2 2025, and down 3.14% quarter-over-quarter from 75.42% in Q1 2026.
Gsk (GSK) Gross Margin (2009 - 2026) Analysis & Trends
Gsk's Gross Margin history runs 18 years deep, the most recent figure standing at 73.05% for Q2 2026.
- In Q2 2026, Gross Margin rose 16.0% year-over-year to 73.05%; the TTM figure through Jun 2026 stood at 73.81% (up 114.0% YoY), while the FY2025 annual figure was 72.4%, up 123.0% from the prior year.
- Gross Margin for Q2 2026 stood at 73.05%, down from 75.42% in the prior quarter.
- The five-year high for Gross Margin was 75.42% in Q1 2026, with the low at 62.21% in Q1 2022.
- The 5-year median for Gross Margin is 72.97% (2025), against an average of 71.52%.
- The sharpest annual moves came in 2022 and 2023: Gross Margin slumped 570 bps in 2022, then jumped 984 bps in 2023.
- Gsk's Gross Margin stood at 65.34% in 2022, then grew by 11 bps to 72.57% in 2023, then climbed by 1 bps to 73.16% in 2024, then increased by 1 bps to 73.54% in 2025, then retreated by 1 bps to 73.05% in 2026.
- Business Quant data shows GSK's Gross Margin at 73.05% in Q2 2026, 75.42% in Q1 2026, and 73.54% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 72.78% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 73.05% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 80.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.05% |
| Mar 31, 2026 | 75.42% |
| Dec 31, 2025 | 73.54% |
| Sep 30, 2025 | 73.58% |
| Jun 30, 2025 | 72.89% |
| Mar 31, 2025 | 74.23% |
| Dec 31, 2024 | 73.16% |
| Sep 30, 2024 | 70.08% |
| Jun 30, 2024 | 73.08% |
| Mar 31, 2024 | 73.24% |
| Dec 31, 2023 | 72.57% |
| Sep 30, 2023 | 72.11% |
| Jun 30, 2023 | 73.08% |
| Mar 31, 2023 | 72.05% |
| Dec 31, 2022 | 65.34% |
| Sep 30, 2022 | 69.05% |
| Jun 30, 2022 | 68.60% |
| Mar 31, 2022 | 62.21% |
| Dec 31, 2021 | 66.95% |
| Sep 30, 2021 | 69.58% |